Società DiaMedica Therapeutics Inc. Toronto S.E.
Azioni
DMA
CA25253X2077
Biotecnologia
Attività
Numero di dipendenti: 19
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Rick Pauls
CEO | Chief Executive Officer | 52 | 01/04/05 |
Scott Kellen
DFI | Director of Finance/CFO | 59 | 01/04/18 |
Ambarish Shah
CTO | Chief Tech/Sci/R&D Officer | - | 01/05/23 |
Chief Tech/Sci/R&D Officer | 62 | 22/01 | |
James Parsons
BRD | Director/Board Member | 58 | 20/10/10 |
Paul Papi
IRO | Public Communications Contact | - | 01/12/16 |
Corporate Officer/Principal | - | - | |
Dominic Cundari
PRN | Corporate Officer/Principal | - | 01/02/22 |
David Wambeke
PRN | Corporate Officer/Principal | - | 11/04/23 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Richard Kuntz
BRD | Director/Board Member | 66 | 30/05/23 |
Tanya Lewis
BRD | Director/Board Member | 53 | 01/03/23 |
James Parsons
BRD | Director/Board Member | 58 | 20/10/10 |
Michael Giuffre
BRD | Director/Board Member | 68 | 10/08/10 |
Rick Pauls
CEO | Chief Executive Officer | 52 | 01/04/05 |
Richard Pilnik
CHM | Chairman | 67 | 01/05/09 |
Charles Semba
BRD | Director/Board Member | 64 | 15/07/21 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 37 963 916 | 23 523 153 ( 61,96 %) | 0 | 61,96 % |
Coordinate società
DiaMedica Therapeutics, Inc.
301 Carlson Parkway Suite 210
55305, Minneapolis
+
http://www.diamedica.comSettore
Variaz. 1 gen. | Capi. | |
---|---|---|
+8,85% | 114 Mrd | |
+11,48% | 104 Mrd | |
-12,76% | 22,41 Mrd | |
-1,05% | 22,28 Mrd | |
-5,29% | 19,07 Mrd | |
-38,29% | 18 Mrd | |
-3,38% | 17,89 Mrd | |
+7,99% | 14,28 Mrd | |
+34,38% | 12,55 Mrd |